Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Sep 1;22(129):273-80.
doi: 10.1183/09059180.00003013.

Significance of connective tissue diseases features in pulmonary fibrosis

Vincent Cottin  1
Affiliations
Review

Significance of connective tissue diseases features in pulmonary fibrosis

Vincent Cottin. Eur Respir Rev. .

Abstract

Interstitial lung disease (ILD) can occur in any of the connective tissue diseases (CTD) with varying frequency and severity, and an overall long-term prognosis that is less severe than that of idiopathic pulmonary fibrosis (IPF). Because ILD may be the presenting manifestation of CTD and/or the dominant manifestation of CTD, clinical extra-thoracic manifestations should be systematically considered in the diagnostic approach of ILD. When present, autoantibodies strongly contribute to the recognition and classification of the CTD. Patients with clinical extrathoracic manifestations of CTD and/or autoantibodies (especially with a high titer and/or the antibody is considered "highly specific" of an autoimmune condition), but who do not fit with established international CTD criteria may be called undifferentiated CTD or "lung-dominant CTD". Although it remains to be determined which combination of symptoms and serologic tests best identify the subset of patients with clinically relevant CTD features, available evidence suggests that such patients may have distinct clinical and imaging presentation and may portend a distinct clinical course. However, autoantibodies alone when present in IPF patients do not seem to impact prognosis or management. Referral to a rheumatologist and multidisciplinary discussion may contribute to management of patients with undifferentiated CTD.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: Disclosures can be found alongside the online version of this article at err.ersjournals.com

Figures

Figure 1.
Figure 1.
High-resolution computed tomography scan of a 59-year-old female patient with undifferentiated connective tissue disease, showing patterns of nonspecific interstitial pneumonia (with ground-glass opacification and traction bronchiectasis) and oesophageal dilation. Features of systemic sclerosis were present (Raynaud's phenomenon, megacapillaries at nailfold capillaroscopy, oesophageal hypomotility, anti-topoisomerase-1 antibodies), but no sclerodactily or telangiectasia was visible at 5 years follow-up.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Fischer A, du Bois R. Interstitial lung disease in connective tissue disorders. Lancet 2012; 380: 689–698. - PubMed
    1. Antin-Ozerkis D, Rubinowitz A, Evans J, et al. . Interstitial lung disease in the connective tissue diseases. Clin Chest Med 2012; 33: 123–149. - PubMed
    1. Park JH, Kim DS, Park IN, et al. . Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med 2007; 175: 705–711. - PubMed
    1. Navaratnam V, Ali N, Smith CJ, et al. . Does the presence of connective tissue disease modify survival in patients with pulmonary fibrosis? Respir Med 2011; 105: 1925–1930. - PubMed
    1. Kinder BW, Collard HR, Koth L, et al. . Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? Am J Respir Crit Care Med 2007; 176: 691–697. - PMC - PubMed

MeSH terms

LinkOut - more resources